ADVANCED ENZYME TECHNOLOGIES
Back to Cashflow Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹12 Cr | ₹-19 Cr | ₹17 Cr | ₹-184 Cr | ₹70 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹12 Cr |
| Mar2025 | ₹-19 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹-184 Cr |
| Mar2022 | ₹70 Cr |
How is Net Cash Inflow / Outflow of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹12 Cr | Positive | |
| Mar2025 | ₹-19 Cr | Negative | |
| Mar2024 | ₹17 Cr | Positive | |
| Mar2023 | ₹-184 Cr | Negative | |
| Mar2022 | ₹70 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,325.8 Cr | -1.8% | -4% | -3.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -1.8% |
-4% |
-3.5% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses